A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

Hiroyuki Takamatsu; Rachel K. Wee; Yoshitaka Zaimoku; Ryoichi Murata; Jianbiao Zheng; Martin Moorhead; Victoria E.H. Carlton; Katherine A. Kong; Naoki Takezako; Shigeki Ito; Toshihiro Miyamoto; Kenji Yokoyama; Kosei Matsue; Tsutomu Sato; Toshiro Kurokawa; Hideo Yagi; Yasushi Terasaki; Kinya Ohata; Morio Matsumoto; Takashi Yoshida; Malek Faham; Shinji Nakao

doi:10.1111/bjh.15002

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

Hiroyuki Takamatsu, Rachel K. Wee, Yoshitaka Zaimoku, Ryoichi Murata, Jianbiao Zheng, Martin Moorhead, Victoria E.H. Carlton, Katherine A. Kong, Naoki Takezako, Shigeki Ito, Toshihiro Miyamoto, Kenji Yokoyama, Kosei Matsue, Tsutomu Sato, Toshiro Kurokawa, Hideo Yagi, Yasushi Terasaki, Kinya Ohata, Morio Matsumoto, Takashi YoshidaMalek Faham, Shinji Nakao

Internal Medicine

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	664-668
Number of pages	5
Journal	British Journal of Haematology
Volume	183
Issue number	4
DOIs	https://doi.org/10.1111/bjh.15002
Publication status	Published - Nov 2018

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1111/bjh.15002

Cite this

Takamatsu, H., Wee, R. K., Zaimoku, Y., Murata, R., Zheng, J., Moorhead, M., Carlton, V. E. H., Kong, K. A., Takezako, N., Ito, S., Miyamoto, T., Yokoyama, K., Matsue, K., Sato, T., Kurokawa, T., Yagi, H., Terasaki, Y., Ohata, K., Matsumoto, M., ... Nakao, S. (2018). A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. British Journal of Haematology, 183(4), 664-668. https://doi.org/10.1111/bjh.15002

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. / Takamatsu, Hiroyuki; Wee, Rachel K.; Zaimoku, Yoshitaka; Murata, Ryoichi; Zheng, Jianbiao; Moorhead, Martin; Carlton, Victoria E.H.; Kong, Katherine A.; Takezako, Naoki; Ito, Shigeki; Miyamoto, Toshihiro; Yokoyama, Kenji; Matsue, Kosei; Sato, Tsutomu; Kurokawa, Toshiro; Yagi, Hideo; Terasaki, Yasushi; Ohata, Kinya; Matsumoto, Morio; Yoshida, Takashi; Faham, Malek; Nakao, Shinji.

In: British Journal of Haematology, Vol. 183, No. 4, 11.2018, p. 664-668.

Research output: Contribution to journal › Letter › peer-review

Takamatsu, H, Wee, RK, Zaimoku, Y, Murata, R, Zheng, J, Moorhead, M, Carlton, VEH, Kong, KA, Takezako, N, Ito, S, Miyamoto, T, Yokoyama, K, Matsue, K, Sato, T, Kurokawa, T, Yagi, H, Terasaki, Y, Ohata, K, Matsumoto, M, Yoshida, T, Faham, M & Nakao, S 2018, 'A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation', British Journal of Haematology, vol. 183, no. 4, pp. 664-668. https://doi.org/10.1111/bjh.15002

Takamatsu H, Wee RK, Zaimoku Y, Murata R, Zheng J, Moorhead M et al. A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. British Journal of Haematology. 2018 Nov;183(4):664-668. https://doi.org/10.1111/bjh.15002

Takamatsu, Hiroyuki ; Wee, Rachel K. ; Zaimoku, Yoshitaka ; Murata, Ryoichi ; Zheng, Jianbiao ; Moorhead, Martin ; Carlton, Victoria E.H. ; Kong, Katherine A. ; Takezako, Naoki ; Ito, Shigeki ; Miyamoto, Toshihiro ; Yokoyama, Kenji ; Matsue, Kosei ; Sato, Tsutomu ; Kurokawa, Toshiro ; Yagi, Hideo ; Terasaki, Yasushi ; Ohata, Kinya ; Matsumoto, Morio ; Yoshida, Takashi ; Faham, Malek ; Nakao, Shinji. / A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation. In: British Journal of Haematology. 2018 ; Vol. 183, No. 4. pp. 664-668.

@article{a4448f6e2f7e4ac2bb532fe7b68da90f,

title = "A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation",

author = "Hiroyuki Takamatsu and Wee, {Rachel K.} and Yoshitaka Zaimoku and Ryoichi Murata and Jianbiao Zheng and Martin Moorhead and Carlton, {Victoria E.H.} and Kong, {Katherine A.} and Naoki Takezako and Shigeki Ito and Toshihiro Miyamoto and Kenji Yokoyama and Kosei Matsue and Tsutomu Sato and Toshiro Kurokawa and Hideo Yagi and Yasushi Terasaki and Kinya Ohata and Morio Matsumoto and Takashi Yoshida and Malek Faham and Shinji Nakao",

note = "Funding Information: We would like to acknowledge Drs Yoshiyasu Ogawa and Nor-iko Kobayashi of LSI Medience Corporation and Ms Rie Oumi and Ms Tomoko Tanaka of Kanazawa University for their technical assistance. This research project was supported by the following grants: a Grant-in-Aid for Scientific Research (C) (15K08644), Research Award from the Mitsui Life Social Welfare Foundation, Research Award from the International Myeloma Foundation Japan, and Research Award from the Hokkoku Foundation for Cancer Research (H.T.). This study was supported in part by research funding from Adaptive Biotechnologies (J.Z, M.M, V.E.H.C, K.A.K, M.F.). Funding Information: H.T. received research funding from Takeda and Fujimoto, and honoraria from Celgene and Janssen. S.I. received research funding from Bristol-Myers Squibb and honoraria from Celgene. K.Y. received research funding from Takeda and honoraria from Celgene. J. Z., M.M., V. E. H. C., K. A. K. and M.F. are employees of Adaptive Biotechnologies. The remaining authors declare no competing financial interests.",

year = "2018",

month = nov,

doi = "10.1111/bjh.15002",

language = "English",

volume = "183",

pages = "664--668",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation

AU - Takamatsu, Hiroyuki

AU - Wee, Rachel K.

AU - Zaimoku, Yoshitaka

AU - Murata, Ryoichi

AU - Zheng, Jianbiao

AU - Moorhead, Martin

AU - Carlton, Victoria E.H.

AU - Kong, Katherine A.

AU - Takezako, Naoki

AU - Ito, Shigeki

AU - Miyamoto, Toshihiro

AU - Yokoyama, Kenji

AU - Matsue, Kosei

AU - Sato, Tsutomu

AU - Kurokawa, Toshiro

AU - Yagi, Hideo

AU - Terasaki, Yasushi

AU - Ohata, Kinya

AU - Matsumoto, Morio

AU - Yoshida, Takashi

AU - Faham, Malek

AU - Nakao, Shinji

N1 - Funding Information: We would like to acknowledge Drs Yoshiyasu Ogawa and Nor-iko Kobayashi of LSI Medience Corporation and Ms Rie Oumi and Ms Tomoko Tanaka of Kanazawa University for their technical assistance. This research project was supported by the following grants: a Grant-in-Aid for Scientific Research (C) (15K08644), Research Award from the Mitsui Life Social Welfare Foundation, Research Award from the International Myeloma Foundation Japan, and Research Award from the Hokkoku Foundation for Cancer Research (H.T.). This study was supported in part by research funding from Adaptive Biotechnologies (J.Z, M.M, V.E.H.C, K.A.K, M.F.). Funding Information: H.T. received research funding from Takeda and Fujimoto, and honoraria from Celgene and Janssen. S.I. received research funding from Bristol-Myers Squibb and honoraria from Celgene. K.Y. received research funding from Takeda and honoraria from Celgene. J. Z., M.M., V. E. H. C., K. A. K. and M.F. are employees of Adaptive Biotechnologies. The remaining authors declare no competing financial interests.

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85038881461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038881461&partnerID=8YFLogxK

U2 - 10.1111/bjh.15002

DO - 10.1111/bjh.15002

M3 - Letter

C2 - 29270982

AN - SCOPUS:85038881461

VL - 183

SP - 664

EP - 668

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -